Skip to main content
TipRanks
Go Ultimate75% OFF

Anthony Maddaluna Insider Profile

4 Followers

Anthony Maddaluna, Director at Indaptus Therapeutics, holds 53.57K shares in Indaptus Therapeutics (Ticker: INDP), holds 2.85K shares in Albany Molecular Research (Ticker: AMRI), holds 176.79K shares in Pfizer (Ticker: PFE). Most recently, Anthony Maddaluna Bought ― shares of Indaptus Therapeutics on Aug 29, 2019 for an estimated value of $11.75K.

Anthony Maddaluna's Trading History

INDP
Indaptus Therapeutics
Aug 29, 2019DirectorInformative Buy11.75K$184.82K
AMRI
Albany Molecular Research
Sep 05, 2017―Uninformative Sell243.82K$62.05K
PFE
Pfizer
Nov 10, 2016EVPInformative Sell330.00K$5.10M

You May Also Like

Anthony Maddaluna insider profile FAQ

What is the percentage of profitable transactions made by Anthony Maddaluna?
The percentage of profitable transactions made by Anthony Maddaluna is 25%.
What is the average return per transaction made by Anthony Maddaluna?
The average return per transaction made by Anthony Maddaluna is -9.80%.
What stocks does Anthony Maddaluna hold?
Anthony Maddaluna holds: INDP, AMRI, PFE stocks.
What was Anthony Maddaluna’s latest transaction?
Anthony Maddaluna’s latest transaction was an Informative Buy of $11.75K.
What was Anthony Maddaluna's most profitable transaction?
Anthony Maddaluna’s most profitable transaction was an Informative Sell of PFE stock on February 13, 2015. The return on the trade was 12.30%.
What is Anthony Maddaluna's role in Indaptus Therapeutics?
Anthony Maddaluna's role in Indaptus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.